| NMN Symposium 2027 Day 1 (Thursday April 22nd 2027) |
| 09.45 – 10.00 Welcome and Introduction |
| Nuclear Medicine meets Neuro-Oncology. Nathalie L. Albert (Munich), Matthias Preusser (Vienna) |
| 10.00 – 12.00 Clinical trials 2.0 in Neuro-Oncology. Chairs: Julia Furtner (Vienna), Wolfgang Wick (Heidelberg) |
| The need for smart trials – strategic development in Neuro-Oncology. Keynote Lecture – Timothy Cloughesy (Los Angeles) 30’ + 15’ |
| Imaging 2.0: |
- Implementation of novel MRI parameters into clinical trials – are we there yet? Ben Ellingson (Los Angeles) 15’
|
- Implementation of PET into clinical trials – are we there yet? Derek Johnson 15’
|
- Implementation of AI-based image analysis into clinical trials – are we there yet? tbd, 15’
|
- Panel discussion – all speakers, 30’
|
| 12.00 – 13.00 Lunch Break |
| 13.00 – 14.30 Theranostics 2.0 in Neuro-Oncology. Chairs: Nathalie Albert (Munich), Nelleke Tolboom (Utrecht) |
| Strategic evidence generation for theranostics Matthias Preusser (Vienna) 15’+5’ |
| Novel targets, novel radionuclides – current trends in theranostics – Ken Herrmann (Essen) 15’+5’ |
| Are we ready for theranostics in clinical routine? – Andrew Scott (Melbourne) 15’+5’ |
| Panel discussion – all speakers, 30’ |
| 14.30 – 15.30 Proffered papers I: Hot data and burning questions. Chairs: tbd |
| Oral presentations from selected abstracts (7 abstracts; 5’ + 3’) |
| 15.30 – 16.30 NMN Posters viewing with Coffee and Cake |
| 16.30 – 17.30 Proffered papers II: Hot data and burning questions. Chairs: tbd |
| Oral presentations from selected abstracts (7 abstracts; 5’ + 3’) |
| From 19.00 Networking Event “Rathauskeller” |
| NMN Symposium 2027 Day 2 (Friday April 22nd 2027) |
| 09.00 – 09.45 Networking Coffee |
| Ali Landman (Lancet Medical Imaging and Theranostics), David Collingridge (Lancet Oncology), Susan Chang (Neuro-Oncology, RANO), Ken Herrmann (JNM) |
| 09.45 – 11.00 Clinical Neuro-Oncology 2.0 – new classifications and guidelines. Chairs: Patrick Wen (Boston), Roberta Ruda (Turin) |
| CNS WHO classification 2027 Felix Sahm (Heidelberg) 15’+10’ |
| WFNOS Guideline 2027 Michael Weller (Zurich) 15’ + 10’ |
| From research to clinical care – maximizing the impact of science Wolfgang Wick (Heidelberg) 15’ + 10’ |
| 11.00 – 12.00 Satellite Symposium I |
| 12.00 – 13.00 NMN Lunch |
| 13.00 – 14.00 Satellite Symposium II |
| 14:00 – 15:00 Developments in meningioma management – current trials and controversies. Chairs: tbd |
| Clinial trial landscape David Raleigh (San Francisco) 10’ + 5’ |
| PET imaging of meningioma: must have or nice to have? Point-counterpoint debate |
- Point: the case for SSTR PET imaging of meningiomas, Johnny Duerinck (Brussels), 10´+ 5’
|
- Counterpoint: the case against SSTR PET imaging of meningiomas, Michael Jenkinson (Liverpool),
10´ + 5’
|
|
|
| 15.00 – 16.00 NMN Coffee |
| 16:00 – 17:00 Clinical trials in progress. Chairs: tbd |
| Oral presentations from selected abstracts (7 abstracts; 5’ + 3’) |
| 17.00 Conclusion and Farewell Drinks |
| Nathalie L. Albert (Munich), Matthias Preusser (Vienna) |
